{"filing":{"accession_number":"0001142750-26-000008","cik":"0001142750","ticker":"AMN","company_name":"AMN HEALTHCARE SERVICES INC","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"amn-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1142750/000114275026000008/amn-20260806.htm"},"events":[{"id":25460,"run_id":23111,"accession_number":"0001142750-26-000008","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"AMN Healthcare disclosed its second quarter 2026 financial results on August 6, 2026, reporting consolidated revenue of $673.2 million, net income of $21.2 million ($0.53 per diluted share), and adjusted EBITDA of $73.4 million. The press release, furnished as Exhibit 99.1, presents comprehensive quarterly financial results including segment performance, margin analysis, cash position, and forward guidance for Q3 2026. This is a standard earnings release disclosure under Item 2.02.","company_name":"AMN HEALTHCARE SERVICES INC","ticker":"AMN","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26297,"accession_number":"0001142750-26-000008","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"AMN Healthcare disclosed its second quarter 2026 financial results on August 6, 2026, reporting consolidated revenue of $673.2 million, net income of $21.2 million ($0.53 per diluted share), and adjusted EBITDA of $73.4 million. The press release, furnished as Exhibit 99.1, presents comprehensive quarterly financial results including segment performance, margin analysis, cash position, and forward guidance for Q3 2026. This is a standard earnings release disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:46:48.786108+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26297,"accession_number":"0001142750-26-000008","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"AMN Healthcare disclosed its second quarter 2026 financial results on August 6, 2026, reporting consolidated revenue of $673.2 million, net income of $21.2 million ($0.53 per diluted share), and adjusted EBITDA of $73.4 million. The press release, furnished as Exhibit 99.1, presents comprehensive quarterly financial results including segment performance, margin analysis, cash position, and forward guidance for Q3 2026. This is a standard earnings release disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:46:48.786108+00:00","company_name":"AMN HEALTHCARE SERVICES INC","ticker":"AMN","filing_date":"2026-08-06"}]}